Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs

Clinical Pharmacokinetics

Volumn 34, Issue 3, 1998, Pages 203-218

  Kashuba, Angela D M ^a   Nafziger, Anne N ^a,b  

^a BASSETT RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

CARDIOVASCULAR FUNCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG PROTEIN BINDING; ESTRUS CYCLE; FEMALE; HEMATOLOGY; HUMAN; IMMUNE SYSTEM; KIDNEY FUNCTION; MENSTRUAL CYCLE; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

CHRONOBIOLOGY; FEMALE; HUMANS; MENSTRUAL CYCLE; PHARMACOKINETICS; PHARMACOLOGY;

EID: 0031891641     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199834030-00003     Document Type: Review

References (132)

1. Nicholas GS, Barron DH. The use of sodium amytal in the production of anesthesia in the rat. J Pharmacol Exp Ther 1932; 46: 125-9
2. Brandstetter Y, Kaplanski J, Leibson V, et al. The effects of estrus cycle on drug metabolism in the rat. Eur J Drug Metab Pharmacokinet 1986; 11 (4): 251-4
3. Kato R. Sex-related differences in drug metabolism. Drug Metab Rev 1974; 3: 1-31
4. Skett P. Biochemical basis of sex differences in drug metabolism. Pharmacol Ther 1988; 38: 269-304
5. Gleiter CH, Gundert-Remy U. Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet 1996; 21: 123-8
6. Fletcher CV, Acosta EP, Strykowski JM. Gender differences in human pharmacokinetics and pharmacodynamics. J Adolesc Health 1994; 15: 619-29
7. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50 (2): 222-39
8. Giudicelli JF, Tillement JP. Influence of sex on drug kinetics in man. Clin Pharmacokinet 1977; 2: 157-66
9. Bonate PL. Gender-related differences in xenobiotic metabolism. J Clin Pharmacol 1991; 31: 684-90
10. Food and Drug Administration. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs. Fed Regist 1993; 58 (139): 39406-16
11. Merkatz RB, Temple R, Sobel S, et al. Working Group on Women in Clinical Trials (1993). Women in clinical trials of new drugs: a change in Food and Drug Administration policy. N Engl J Med 1993; 329: 292-6
12. Shaw RW. Neuroendocrinology of the menstrual cycle in humans. Clin Endocrinol Metab 1983; 531-59
13. 2-microglobulin and serum water during the menstrual cycle. Acta Med Scand 1987; 221: 191-7
14. Nafziger AN, Schwartzman MS, Bertino JS. Absence of tobramycin pharmacokinetic and creatinine clearance variation during the menstrual cycle: implied absence of variation in glomerular filtration rate. J Clin Pharmacol 1989; 29 (8): 757-63
15. Forsling M, Akerlun DM, Stromberg P. Variations in plasma concentrations of vasopressin during the menstrual cycle. J Endocrinol 1981; 89: 263-6
16. Katz FH, Romf HP. Plasma aldosterone and renin activity during the menstrual cycle. J Clin Endocrinol Metab 1972; 34: 819-23
17. Olson BR, Forman MR, Lanza E, et al. Relation between sodium balance and menstrual cycle symptoms in normal women. Ann Intern Med 1996; 125: 564-7
18. Parboosingh J, Doig A, Michie EA. Changes in renal water and electrolyte excretion occurring before and after induced ovulation and their relation to total oestrogen and pregnanediol excretion. J Obstet Gynaecol Br Commonw 1974; 81 (6): 417-22
19. Yeko TR, Rao PS, Parsons AK, et al. Atrial natriuretic peptide. oestradiol and progesterone in women undergoing spontaneous and gonadotrophin-stimulated ovulatory cycles. Hum Reprod 1995; 10 (11): 2872-4
20. Albano JD, Campbell SK, Farrer A, et al. Gender differences in urinary kallikrein excretion in man: variation throughout the menstrual cycle. Clin Sci 1994; 86 (2): 227-31
21. Wald A, Van Thiel DH, Hoeschstetter L, et al. Gastrointestinal transit: effect of the menstrual cycle. Gastroenterology 1981; 80: 1497-500
22. Mones J, Carrio I, Calabuig R, et al. Influence of the menstrual cycle and of menopause on the gastric emptying rate of solids in female volunteers. Eur J Nucl Med 1993; 20: 600-2
23. Hsu JJ, Kin CH, O'Connor MK, et al. Effect of menstrual cycle on esophageal emptying of liquid and solid boluses. Mayo Clin Proc 1993; 68: 753-6
24. Miller SB, Sita A. Parental history of hypertension, menstrual cycle phase, and cardiovascular response to stress. Psychosom Med 1994; 56: 61-9
25. Dunne FP, Barry DG, Ferriss JB, et al. Changes in blood pressure during the normal menstrual cycle. Clin Sci 1991; 81: 515-8
26. Durrington PN. Biological variation in serum lipid concentrations. Scand J Clin Lab Invest 1990; 198 Suppl.: 86-91
27. Tersman Z, Collins A, Eneroth P. Cardiovascular responses to psychological and physiological stressors during the menstrual cycle. Psychosom Med 1991; 53: 185-97
28. Jern C, Manhem K, Eriksson E, et al. Hemostatic responses to mental stress during the menstrual cycle. Thromb Haemost 1991; 66: 614-8
29. Basdevant A, De Lignieres B, Bigorie B, et al. Estradiol, progesterone, and plasma lipids during the menstrual cycle. Diabete Metab 1981; 7: 1-4
30. Reed RG, Pearson TA, Stewart PW, et al. Variance in serum lipids and lipoproteins with menstrual cycle in premenopausal women is no greater than variance in postmenopausal women or men. Circulation 1995; 91: 923
31. Heiling VJ, Jensen MD. Free fatty acid metabolism in the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab 1992; 74: 806-10
32. Pansini F, Piccolo R, Bassi P, et al. Basal and forskolin-stimulated cyclic adenosine monophosphate in intact human platelets during the menstrual cycle. Am J Obstet Gynecol 1986; 154: 679-82
33. Cederblad G, Hahn L, Korsan-Bengtsen K, et al. Variations in blood coagulation, fibrinolysis, platelet function, and various plasma proteins during the menstrual cycle. Haemostasis 1977; 6: 294-302
34. Larsen LF, Andersen HR, Hansen AB, et al. Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variation in glutathione peroxidase, homeostatic variables, lipids and lipoproteins in healthy young women. Scand J Clin Lab Invest 1996; 56: 241-9
35. Mathur S, Mathur RS, Goust JM, et al. Cyclic variations in white cell subpopulations in the human menstrual cycle: correlations with progesterone and estradiol. Clin Immunol Immunopathol 1979; 13: 246-53
36. Bisdee JT, Garlick PJ, James WPT. Metabolic changes during the menstrual cycle. Br J Nutr 1989; 61: 641-50
37. Christy NP, Shaver JC. Estrogens and the kidney. Kidney Int 1974; 6: 366-76
38. Harvey AM, Malvin RL, Vander AJ. Comparison of creatinine secretion in men and women. Nephron 1966; 3: 201-5
39. Davidson JM, Noble MCB. Serial changes in 24 hour creatinine clearance during normal menstrual cycle and the first trimester of pregnancy. Br J Obstet Gynaecol 1981; 88: 10-7
40. Singer JS, Brandt LJ. Pathophysiology of the gastrointestinal tract during pregnancy. Am J Gastroenterol 1991; 86: 1695-712
41. Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989; 96: 11-7
42. Horowitz M, Maddern J, Chatterton E, et al. The normal menstrual cycle has no effect on gastric emptying. Br J Obstet Gynaecol 1985; 92: 743-6
43. Thurnbull GK, Thompson DG, Day S, et al. Relationships between symptoms, menstrual cycle and oro-cecal transit in normal and constipated women. Gut 1989; 30: 30-4
44. Sweeting J. Does the time of the month affect the function of the gut? Gastroenterology 1992; 102: 1084-5
45. Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut 1996; 39: 299-305
46. Little BC, Zahn TP. Changes in mood and autonomic functioning during the menstrual cycle. Psychophysiology 1974; 11: 579-90
47. Girdler SS, Pedersen CA, Stern RA, et al. The menstrual cycle and premenstrual syndrome: modifiers of cardiovascular reactivity in women. Health Psychol 1993; 12: 180-92
48. Girdler SS, Kight KC. Hemodynamic stress responses in men and women examined as a function of female menstrual cycle phase. Int J Psychophysiol 1994; 17: 233-48
49. Kharitonov SA, Logan-Sinclair RB, Bussett CM, et al. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J 1994; 72: 243-5
50. Kaplan BJ, Whitsett SF, Robinson JW. Menstrual cycle phase is a potential confounder in psychophysiology research. Psychophysiology 1990; 27: 445-50
51. Karpanou EA, Vyssoulis GP, Georgoudi DG, et al. Disparate serum lipid changes between normotensive and hypertensive women during the menstrual cycle. Am J Cardiol 1992; 70: 111-3
52. Schijf CPT, van der Mooren MJ, Doesburg WH, et al. Difference in serum lipids, lipoprotein, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle. Acta Endocrinol 1993; 129: 130-6
53. Lebech AM, Kjaer A, Lebech PE. Metabolic changes during the normal menstrual cycle: a longitudinal study. Am J Obstet Gynecol 1990; 163: 414-6
54. Reed RG, Pearson TA, Stewart PW, et al. Do premenopausal women exhibit significant biologic variability in plasma lipids as a function of menstrual status. Clin Chem 1995; 41: S136
55. Clark BA, Elahi D, Epstein FH. The influence of gender, age, and the menstrual cycle on plasma atrial natriuretic peptide. J Clin Endocrinol Metab 1990; 70: 349-52
56. Trigoso WF, Wesly JM, Meranda DL, et al. Vasopressin and atrial natriuretic hormone response to hypertonic saline during the follicular and luteal phases of the menstrual cycle. Hum Reprod 1996; 11 (11): 2392-5
57. Janowsky DS, Berens SC, Davis JM. Correlations between mood, weight, and electrolytes during the menstrual cycle: a renin-angiotensin-aldosterone hypothesis of premenstrual tension. Psychosom Med 1973; 325: 143-53
58. Reeves BD, Garvin JE, McElin TW. Premenstrual tension: symptoms and weight changes related to potassium therapy. Am J Obstet Gynecol 1971; 109: 1036-41
59. Dadlani AG, Chandwani S, Desai CA, et al. Serum electrolytes during various phases of menstrual cycle. Indian J Physiol Pharmacol 1982; 26: 302-6
60. Stephenson LA, Kolka MA, Wilkerson JF. Metabolic and thermoregulatory responses to exercise in menstrual cycles of athletic and non-athletic women. Med Sci Sports Exerc 1982; 14: 270-5
61. Williams CL, Stancel GM. Estrogens and progestins. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 1411-58
62. Gleichauf CN, Roe DA. The menstrual cycle's effect on the reliability of bioimpedance measurements for assessing body composition. Am J Clin Nutr 1989; 50: 903-7
63. Webb P. 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr 1986; 55: 637-40
64. Nicklas BJ, Hackney AC, Sharp RL, et al. The menstrual cycle and exercise: performance, muscle glycogen, and substrate responses. Int J Sports Med 1989; 10: 264-9
65. Craft IL, Wise IJ. Changes in amino acid metabolism during the menstrual cycle. J Obstet Gynaecol Br Commonw 1969; 76: 928-33
66. Toth EL, Suthijumroon A, Crockford PM, et al. Insulin action does not change during the menstrual cycle in normal women. J Clin Endocrinol Metab 1987; 64: 74-80
67. Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 1995; 17 (2): 265-86
68. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases: mechanism of a sex hormone action. Am J Pathol 1985; 121: 531-51
69. Polan ML, Kuo A, Loukides J, et al. Cultured human luteal peripheral monocyles secrete increased levels of interleukin-1. J Clin Endocrinol Metab 1990; 70: 480-4
70. 2 from human monocytes isolated in the luteal phase of the menstrual cycle: implications for immunity? Prostaglandins 1994; 47: 41-54
71. Sulke AN, Jones DB, Wood PJ. Variation in natural killer activity in peripheral blood during the menstrual cycle. BMJ (Clin Res Ed) 1985; 290: 884-8
72. Moldotsky H, Lue FA, Shahal B, et al. Diurnal sleep/wake-related immune function during the menstrual cycle of healthy young women. J Sleep Res 1995; 4: 150-9
73. Backstrom T, Jorpes P. Serum phenytoin, phenobarbital, carbamuzepine, albumin and plasma estradiol progesterone concentrations during the menstrual cycle in women with epilepsy. Acta Neurol Scand 1979; 58: 63-71
74. Boggess KA, Williamson HO, Homm RJ. Influence of the menstrual cycle on systemic diseases. Obstet Gynecol Clin North Am 1990; 17 (2): 321-42
75. Serrander AM, Peek KE. Changes in contact lens comfort related to the menstrual cycle and menopause: a review of articles. J Am Optom Assoc 1993; 64 (3): 162-6
76. Dalton K. Influence of menstruation on glaucoma. Br J Ophthalmol 1967; 51 (10): 692-5
77. Qureshi IA. Intraocular pressure: association with menstrual cycle, pregnancy and menopause in apparently healthy women. Chin J Physiol 1995; 38 (4): 229-34
78. Kalogeromitros D, Katsarou A, Armenaka M, et al. Influence of the menstrual cycle on skin-prick test reactions to histamine. morphine and allergen. Clin Exp Allergy 1995; 25 (5): 461-6
79. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry 1996; 153: 163-73
80. Smolensky MH, D'Alonzo GE. Medical chronobiology: concepts and applications. Am Rev Respir Dis 1993; 147 (6 Pt 2): S2-19
81. Gotthardt M, Clark JD, Roy TM. 'Ovarian asthma': fact or fancy? J Ky Med Assoc 1996; 94 (3): 105-8
82. Eliasson O, Scherzer HH, Jr DeGraff AC. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986; 77 (1 Pt 1): 87-94
83. Gibbs CJ, Coutts II, Lock R, et al. Premenstrual exacerbation of asthma. Thorax 1984; 39 (11): 833-6
84. Hanley SP. Asthma variation with menstruation. Br J Dis Chest 1981; 75 (3): 306-8
85. Skobeloff EM, Spivey WH, Silverman R, et al. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996; 156 (16): 1837-40
86. Pauli BD, Reid RL, Munt PW, et al. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respif Dis 1989; 140 (20): 358-62
87. 2-responses to intravenous salbutamol during the menstrual cycle. Eur J Clin Pharmacol 1994; 46: 511-5
88. Tan KS, McFarlane LC, Coutie WJ, et al. Effects of exogenous female sex-steroid hormones on lymphocyte beta 2-adrenoceptors in normal females. Br J Clin Pharmacol 1996; 41 (5): 414-6
89. Herkes GK, Eadie MJ. Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy. Epilepsy Res 1990; 6 (2): 146-54
90. Zimmerman AW. Hormones and epilepsy. Neurol Clin 1986; 4 (4): 853-61
91. Rosciszewska P, Buntner B, Guz I, et al. Ovarian hormones, anticonvulsant drugs, and scizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry 1986; 49 (1): 47-51
92. Duncan S, Read CL, Brodic MJ. How common is catamenial epilepsy? Epilepsia 1993; 34 (5): 827-31
93. Herkes GK, Eadie MJ, Sharbrough F, et al. Patterns of seizure occurrence in catamenial epilepsy. Epilepsy Res 1993; 15 (1): 47-52
94. Morrell MJ. Hormones and epilepsy through the lifetime. Epilepsia 1942; 22 Suppl. 4: S49-S61
95. Herzog AG. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia 1991; 32 Suppl. 6: S27-S33
96. Mattson RH, Cramer JA. Epilepsy, sex hormones, and antiepileptic drugs. Epilapsia 1985; 26 Suppl. 1: S40-S51
97. Backstrom T. Epileptic scizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976; 54: 321-47
98. Rodriguez Macias KA. Catamenial epilepsy: gynecological and hormonal implications. Five case reports. Gynecol Endocrinol 1996; 10 (2): 139-42
99. Jones BM, Jones MK. Alcohol effects in women during the menstrual cycle. Ann NY Acad Sci 1976; 273: 576-87
100. Lammers SMM, Mainzer DEH, Breteler MHM. Do alcohol pharmacokinetics in women vary due to the menstrual cycle? Addiction 1995; 90 (1): 23-30
101. Miaskiewicz SL, Shively CA, Vesell ES. Sex differences in absorption kinetics of sodium salicylate. Clin Pharmacol Ther 1982; 31 (1): 30-7
102. Jochemsen R, van der Graaff M, Boeijinga JK, et al. Influence of sex menstrual cycle and oral contraception on the disposition of nitrazepam. Br J Clin Pharmacol 1982; 13 (3): 319-24
103. Shavit G, Lerman P, Korczyn AD, et al. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology 1984; 34 (7): 959-61
104. Daneshmend TK, Jackson L, Roberts CJC. Physiological and pharmacological variability in estimated hepatic blood flow in man. Br J Clin Pharmacol 1981; 11: 491-6
105. Somani SM, Khurana RC. Mechanism of estrogen-imipramine interaction. JAMA 1973; 223: 560
106. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 1993; 57: 237-57
107. Waxman DJ. Interactions of hepatic cytochromes P450 with steroid hormones. Biochem Pharmacol 1988; 37: 71-84
108. Walle T, Walle UK, Cowart TD, et al. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 1989; 46: 257-63
109. Miners JO, Atwood J, Birkett DJ. Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br J Clin Pharmacol 1983; 16: 503-9
110. Riester EF, Pantuck EJ, Pantuck CB, et al. Antipyrine metabolism during the menstrual cycle. J Pharmacol Ther 1980; 28: 384-91
111. Kellerman G, Luyten-Kellerman M, Horning MG, et al. Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes. Clin Pharmacol Ther 1976; 20: 72-80
112. Bruguerolle B, Toumi M, Fraj E, et al. Influence of menstrual cycle on theophylline pharmacokinetics in asthmatics. Eur J Clin Pharmacol 1990; 39 (1): 59-61
113. Manowitz P, Schull CM. Methaqualone metabolism by rat liver microsomes. Res Commun Chem Pathol Pharmacol 1976; 13 (1): 27-39
114. Oram M, Wilson K, Burnett D, et al. Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine. Eur J Clin Pharmacol 1982; 23 (2): 147-50
115. Oram M, Wilson K, Burnett D. The influence of oral contraceptives on the metabolism of methaqualone in man. Br J Clin Pharmacol 1982; 14 (3): 341-5
116. Abdu-Aguye I, Dunlop D, Patel P, et al. Propranolol pharmacokinetics during the menstrual cycle. Postgrad Med J 1986; 62: 1093-5
117. Gerdin E, Rane A. N-Demethylation of ethylmorphine in pregnant and non-pregnant women and in men: an evaluation of the effects of sex steroids. Br J Clin Pharmacol 1992; 34: 250-5
118. Zeiner AR, Kegg PS. Menstrual cycle and oral contraceptive effects on alcohol pharmacokinetics in Caucasian females. Curr Alcohol 1981; 8: 47-56
119. Miners JO, Atwood J, Birkett DJ. Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br J Clini Pharmacol 1983; 16: 503-9
120. Nayak VK, Kshirsagal NA, Desai KN, et al. Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers. Br J Clin Pharmacol 1988; 26 (5): 604-6
121. Lane JD, Steege JF, Rupp SL, et al. Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol 1992; 43: 543-6
122. Wojcicki J, Gawronska-Szklarz B, Kazimierczyk J, et al. Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases. Arzneimittel Forschung 1979; 29: 350-2
123. Wilson K, Oram M, Horth C, et al. The influence of the menstrual cycle on the metabolism and clearance of methaqualone. Br J Cli Pharmacol 1992; 14: 333-9
124. Brick J, Nathan PE, Westrick E, et al. The effect of menstrual cycle on blood alcohol levels and behavior. J Stud Alcohol 1986; 47: 472-7
125. Kirkwood C, Moore A, Haves P, et al. Influence of menstrual cycle and gender on alprazolam pharmacokinetics. Clin Pharmacol Ther 1991; 50 (4): 404-9
126. Greenblatt DJ, Wright CE. Clinical pharmacokinetics of alprazolam: therapeutic implications. Clin Pharmacokinet 1993; 24 (6): 453-71
127. Lew KH, Ludwig EA, Milad MA, et al. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1993; 54: 402-14
128. Macdonald JL, Herman RJ, Verbeek RK. Sex-difference and the ellects of smoking and oral contraceptive steroids on the kinetics of diflunisal. Eur J Clin Pharmacol 1990; 38: 175-9
129. Cordaro JA, Morse GD, Barlos L, et al. Zidovudine pharmacokinetics in HIV-positive women during different phases of the menstrual cycle. Pharmacotherapy 1993; 13 (4): 369-77
130. Kinney EL, Trautmann J, Gold JA, et al. Underrepresentation of women in new drug trials. Ann Intern Med 1981; 95: 495-9
131. Reinberg A, Smolensky M. Circadian changes of drug disposition in man. Clin Pharmacokinet 1982; 7: 401-20
132. Kawachi I, Colditz GA. Invited commentary: confounding, measurement error, and publication bias in studies of passive smoking. Amer J Epidemiol 1996; 144 (10): 909-15